Efficacy and safety of tralokinumab in adolescents with moderate-to- severe atopic dermatitis: results of the phase 3 ECZTRA 6 trial. J of Skin [Internet]. 2022 Mar. 4 [cited 2025 Jun. 24];6(2):s29. Available from: https://skin.dermsquared.com/skin/article/view/1546